Tag: diabetes
-
Vadadustat Essentials for Healthcare Professionals
What is vadadustat?1 The FDA approved vadadustat (Vafseo®) in March 2024 for the treatment of anemia due to chronic kidney disease (CKD). Vadadustat is only approved for dialysis dependent CKD patients. It is not indicated to replace blood transfusions. What is vadadustat’s mechanism of action? Vadadustat is a hypoxia-inducible factor prolyl hydroxylase (HIF PF) inhibitor.…
-
Systemic review suggests alternative biomarkers in gestational diabetes diagnosis
Gestational diabetes (GDM) diagnosis may receive a makeover thanks to new research. According to a recent systemic review, triglycerides, insulin, and maternal weight have the potential to act as diagnostic biomarkers. GDM treatment outcomes vary between patients. Even with proper treatment, some patients still experience pregnancy complications. This suggests that GDM subtypes exist. The authors…
Dahlia Medical Communications 